About us
Overview
Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
The company holds a unique place on the market with all of its laboratories on one site, 250 highly-qualified professionals and more than 40 years’ expertise at the forefront of analytical sciences.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences. For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Our Vision
Speed up people’s access to new medicines
Our Mission
Quality Assistance provides the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
Our Values
- Respect
- Commitment
- Excellence
History of Quality Assistance
2023
New milestone:
Nathalie Draux succeeds Philippe Draux as CEO of Quality Assistance
New milestone:
More than 250 employees
We are proud to have as many individuals on our Team who are committed to the essential role we play in public health and as an analytical CRO partner with pharmaceutical companies.
2022
Quality Assistance replicates its DNA and expands from 6,000 to 12,000 m²
https://mitose.quality-assistance.com/
2021
Challenge 2015-2021: Quality Assistance achieves its 2015 goal of 500 innovative drugs.
6000 m²
2020
200 team members
Reaching 200 highly qualified team members in August 2020
2019
Food and Drug Administration (USA)
The FDA has successfully inspected Quality Assistance.
2017
BNP Paribas Fortis Private Equity Management S.A. enters the capital and the Board of Directors of Quality Assistance S.A.
2015
New expansion for Quality Assistance
Acquisition of 5 hectares of land opposite its current facilities for future operational capacity increase
2012
Agência Nacional de Vigilância Sanitária (Brazil)
ANVISA successfully inspected Quality Assistance in 2012 to verify compliance with Good Practices in Bioavailability/Bioequivalence of Medicines, in accordance with Law N°9,782/99 and Resolution R.D.C./ANVISA N° 103, of 08 May 2003. Quality Assistance is registered with ANVISA as a contract Bioequivalence facility.
2009
PDMA, GCLP, GCP
Pharmaceuticals and Medical Devices Agency (Japan)
In March 2009, Quality Assistance was successfully inspected by the PDMA and received GMP compliance certification from the Japanese authorities.
Good Clinical Laboratory Practice Compliance
Quality Assistance has adapted its quality system to meet the requirements of sponsors who need the analysis of their samples from clinical trials to be done in accordance with GCLP (Good Clinical Laboratory Practice).
Good Clinical Practice Compliance
Quality Assistance has adapted its quality system to meet the requirements of sponsors who need the analysis of their samples from clinical trials to be done in accordance with GCP (Good Clinical Practice).
2008
Valois S.C.R.L. enters the capital and the Board of Directors of Quality Assistance S.A.
5200 m²
97 employees
2004
Good Laboratory Practice Compliance
Quality Assistance is authorized by the Belgian authorities (Scientific Institute of Public Health) to carry out toxicity studies, residue studies, analytical and clinical chemistry testing, and pharmacokinetic studies according to the requirements of Good Laboratory Practice (GLP) - Directive of the European Commission 2004/9/EEC.
2003
Food and Drug Administration (USA)
The FDA has successfully inspected Quality Assistance. Accordingly, Quality Assistance has been accepted and registered with the FDA as a contract pharmaceutical testing facility (FDA-FEI number 3002367943).
2002
Continuous growth
3200 m²
60 employees
2001
Société Régionale d'Investissement de Wallonie (SRIW S.A.) enters the capital and the Board of Directors of Quality Assistance S.A.
Sambrinvest becomes a Board Observer
1998
Sambrinvest becomes a Member of the Board of Directors
1997
Quality Assistance S.P.R.L. becomes a limited company: Quality Assistance S.A.
1993
PHARMANAL S.P.R.L. is renamed Quality Assistance S.P.R.L.
1992
Move to Donstiennes, Belgium
1200 m²
15 employees
1985
Move to Charleroi, Belgium
200 m²
3 employees
1984
Good Manufacturing Practice Compliance
In accordance with the Royal Decree of 22/09/1966*, Quality Assistance is certified by the Belgian Federal Agency for Medicines and Health Products to perform the analysis of medicinal products.
1982
Company establishment
as PHARMANAL S.P.R.L.